Victorians will soon have access to advanced technology that will make blood tests less painful and more efficient with the expansion of global medical technology company Trajan in Melbourne’s east.
The expansion of the facility will create 40 new jobs and upskill an additional 30 employees.
Trajan is a homegrown developer and manufacturer of scientific and medical devices including the hemaPEN, which promises to revolutionise blood testing by using a small pinprick to collect a single drop of blood, making blood tests less traumatic and more convenient.
Minister for Jobs, Innovation and Trade Martin Pakula said Trajan’s choice to further develop its global HQ in Melbourne and expand its local manufacturing capability will strengthen Victoria’s global reputation as a thriving hub for biotechnology and pharmaceuticals.
Trajan currently has operations in Australia, America, Europe and Asia, and customers in more than 100 countries, but the decision to maintain and grow their global HQ in Melbourne is testament to the medical technologies sector in Victoria supporting companies from startup to multinational exporter.
Founded in Melbourne in 2011, Trajan currently employs about 430 people globally.
Victoria is home to 42 per cent of ASX-listed medical technology and pharmaceutical companies with a combined worth of more than $104 billion, which amounts to more than 60 per cent of the nation’s total.
Trajan Scientific and Medical CEO Stephen Tomisich said the company is pleased to engage the support of the Victorian government, highlighting growth areas where Trajan is developing new devices and technologies to improve measurements for healthcare, food and environmental analysis.